Experimental drug XmAb27564 tested for skin conditions – trial halted early
NCT ID NCT06005792
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tested an experimental drug called XmAb27564 in 23 people with mild-to-severe plaque psoriasis or moderate-to-severe atopic dermatitis. Participants received four doses of the drug or a placebo every two weeks. The main goal was to check safety and tolerability. The study was terminated, so results are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
XmAb27564
What this could lead to
If successful, this could point toward a new treatment option for plaque psoriasis and atopic dermatitis.
What could go wrong
This was a very early (Phase 1) trial that was terminated, so results are limited. The drug may not prove effective or safe in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Clinical Studies, LTD. LLP
Webster, Texas, 77598, United States
-
Clinical Trials Research Institute
Thousand Oaks, California, 91320, United States
-
Driven Research
Coral Gables, Florida, 33134, United States
-
Innovaderm Research Inc.
Montreal, Quebec, H2X 2V1, Canada
-
J&S Studies, Inc
College Station, Texas, 77845, United States
-
San Marcus Research Clinic
Miami Lakes, Florida, 33104, United States
-
Unison Clinical Trials
Sherman Oaks, California, 91403, United States